GSK plc (GSK) is a healthcare company that focuses on developing, manufacturing and commercializing general medicines, specialty medicines and vaccines. It offers drugs for the treatment of diseases such as HIV, respiratory, cancer, immuno-inflammation, anti-viral, central nervous system (CNS), metabolic, cardiovascular, and urogenital, anti-bacterials, dermatology and rare diseases. The company also offers over-the-counter (OTC) products for pain relief, oral health, nutrition, skin health and gastro-intestinal diseases. GSK’s vaccine portfolio covers various diseases including hepatitis, diphtheria, tetanus, whooping cough, rotavirus and HPV infections, measles and bacterial meningitis, among others. The company sells its products through wholesalers, pharmacies, hospitals, physicians and other groups worldwide. GSK is headquartered in Brentford, Middlesex, the UK.
GSK plc premium industry data and analytics
Products and Services
Products | Brands |
---|---|
Specialty Medicines | - |
Vaccines | Advair |
General Medicines | Coreg |
XYZ | XYZ |
XYZ | XYZ |
XYZ | XYZ |
History
History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.
Year | Event | Description |
---|---|---|
2023 | Contracts/Agreements | In May, the company announced a partnership with Amitabh Bachchan to raise awareness about shingles, a painful condition that affects 1 out of 3 adults above the age of 50 years. |
2023 | Stake Sale | In May, the company sold 240 million shares in its consumer healthcare business Haleon at 335 pence per share. |
2023 | Plans/Strategy | In April, the company announced its plans to acquire Bellus Health Inc for US$2.0 billion. |
Competitor Comparison
Key Parameters | GSK plc | Pfizer Inc | Johnson & Johnson | F. Hoffmann-La Roche Ltd | Merck & Co Inc |
---|---|---|---|---|---|
Headquarters | United Kingdom | United States of America | United States of America | Switzerland | United States of America |
City | Brentford | New York | New Brunswick | Basel | Kenilworth |
State/Province | - | New York | New Jersey | - | New Jersey |
No. of Employees | 69,400 | 83,000 | 152,700 | 103,613 | 69,000 |
Entity Type | Public | Public | Public | Public | Public |
Key Financial Charts
Sales Growth

Net Income Growth

Executives
Name | Position | Board | Since | Age |
---|---|---|---|---|
Dame Emma Walmsley | Director; Chief Executive Officer | Executive Board | 2017 | 53 |
Julie Brown | Director; Chief Financial Officer | Executive Board | 2023 | - |
Diana Conrad | Chief People Officer | Senior Management | 2019 | - |
Tony Wood | Chief Scientific Officer | Senior Management | 2022 | - |
Shobie Ramakrishnan | Chief Digital and Technology Officer | Senior Management | 2021 | - |
Non Dignissim Eros | Proin vel | Convallis | 2023 | XY |
Non Dignissim Eros | Proin vel | Convallis | 2023 | XY |
Non Dignissim Eros | Proin vel | Convallis | 2023 | XY |
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Access more premium companies when you subscribe to Explorer
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward